» Articles » PMID: 36300839

Long-term Impact of a Behavioral Weight Management Program on Depression and Anxiety Symptoms: 5-year Follow-up of the WRAP Trial

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Behavioral weight management programs may support short-term mental health; however, limited evidence reports the long-term impacts. This study investigated the impact of behavioral weight management programs on depression and anxiety symptoms at 5 years from baseline.

Methods: The Weight loss Referrals for Adults in Primary care (WRAP) trial randomized 1267 adults with BMI ≥ 28 kg/m to a brief intervention (BI) or commercial behavioral weight management program (WW; formerly Weight Watchers) for 12 or 52 weeks (CP12 and CP52, respectively). Linear regression was used to separately compare 5-year changes in depression and anxiety symptoms (by Hospital Anxiety and Depression Scale) between randomized groups, adjusting for baseline depression/anxiety symptoms, gender, and research center.

Results: A total of 643 (51%) participants attended the 5-year study follow-up visit. There was no evidence of a difference between the randomized groups for 5-year changes in depression (BI: -0.08 ± 3.29; CP12: 0.02 ± 3.01; CP52: -0.09 ± 3.41) or anxiety (BI: 0.16 ± 3.50; CP12: -0.05 ± 3.55; CP52: -0.66 ± 3.59) symptoms.

Conclusions: This study found no evidence that commercial weight management programs differed in 5-year changes in depression and anxiety symptoms, compared with BI. These are average effects; some individuals experienced increases or decreases in symptoms. Future research should investigate who is at most risk of mental health declines and investigate how to support them. Future trials should transparently report long-term mental health outcomes to strengthen understanding.

Citing Articles

Depression and Obesity-Do We Know Everything about It? A Narrative Review.

Debski J, Przybylowski J, Skibiak K, Czerwinska M, Waledziak M, Rozanska-Waledziak A Nutrients. 2024; 16(19).

PMID: 39408350 PMC: 11478673. DOI: 10.3390/nu16193383.


Predictors of Mental Health Outcomes in a Multidisciplinary Weight Management Program for Class 3 Obesity.

Lam A, Piya M, Foroughi N, Mohsin M, Chimoriya R, Kormas N Nutrients. 2024; 16(7).

PMID: 38613100 PMC: 11013199. DOI: 10.3390/nu16071068.


The relationship of within-individual and between-individual variation in mental health with bodyweight: An exploratory longitudinal study.

Mueller J, Ahern A, Jones R, Sharp S, Davies A, Zuckerman A PLoS One. 2024; 19(1):e0295117.

PMID: 38198439 PMC: 10781195. DOI: 10.1371/journal.pone.0295117.


Obesity and psychological distress.

Steptoe A, Frank P Philos Trans R Soc Lond B Biol Sci. 2023; 378(1888):20220225.

PMID: 37661745 PMC: 10475872. DOI: 10.1098/rstb.2022.0225.


Long-term impact of a behavioral weight management program on depression and anxiety symptoms: 5-year follow-up of the WRAP trial.

Jones R, Mueller J, Sharp S, Griffin S, Ahern A Obesity (Silver Spring). 2022; 30(12):2396-2403.

PMID: 36300839 PMC: 9828709. DOI: 10.1002/oby.23570.

References
1.
Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

2.
Alhalel N, Schueller S, OBrien M . Association of changes in mental health with weight loss during intensive lifestyle intervention: does the timing matter?. Obes Sci Pract. 2018; 4(2):153-158. PMC: 5893461. DOI: 10.1002/osp4.157. View

3.
Wynne S, Patel S, Barker R, Jones S, Walsh J, Kon S . Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale. Chron Respir Dis. 2020; 17:1479973120933292. PMC: 7301664. DOI: 10.1177/1479973120933292. View

4.
Ahern A, Wheeler G, Aveyard P, Boyland E, Halford J, Mander A . Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Lancet. 2017; 389(10085):2214-2225. PMC: 5459752. DOI: 10.1016/S0140-6736(17)30647-5. View

5.
Ahern A, Breeze P, Fusco F, Sharp S, Islam N, Wheeler G . Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial. Lancet Public Health. 2022; 7(10):e866-e875. DOI: 10.1016/S2468-2667(22)00226-2. View